Search results for "From Annals of Internal Medicine"
VA and DoD offer guideline on managing type 2 diabetes with summary in Annals
The summary describes ways in which the Veterans Affairs/Department of Defense (VA/DoD) guideline differs from recommendations from the American Diabetes Association, the American Geriatrics Society, and the American Association of Clinical Endocrinologists.
https://diabetes.acponline.org/archives/2017/11/10/5.htm
10 Nov 2017
Metformin use associated with improved outcomes in patients with historical contraindications
A systematic review found that metformin appeared to be associated with lower all-cause mortality in patients with moderate chronic kidney disease, congestive heart failure, or chronic liver disease with hepatic impairment.
https://diabetes.acponline.org/archives/2017/01/13/5.htm
13 Jan 2017
Insulin costs, diabetes and testosterone
An Ideas and Opinions piece explained some of the factors behind insulin prices, and a meta-analysis looked at testosterone levels in men with diabetes.
https://diabetes.acponline.org/archives/2023/09/08/6.htm
8 Sep 2023
Running two tests on single blood sample could provide diabetes diagnosis
In a prospective cohort analysis of patients in the Atherosclerosis Risk in Communities study without diagnosed diabetes at baseline, both fasting glucose and HbA1c level were measured in a single blood sample taken during a visit in 1990 to 1992.
https://diabetes.acponline.org/archives/2018/07/13/6.htm
13 Jul 2018
Synopsis covers ADA update on pharmaceutical management of type 2 diabetes
Experts summarized the latest guidance on medication therapy from the American Diabetes Association (ADA) in a recent article.
https://diabetes.acponline.org/archives/2020/09/11/6.htm
11 Sep 2020
Beyond the Guidelines: Should we screen for type 2 diabetes?
Whether to screen a patient for type 2 diabetes is the focus of a Beyond the Guidelines feature in the Oct. 4 Annals of Internal Medicine.
https://diabetes.acponline.org/archives/2016/10/07/6.htm
7 Oct 2016
Bariatric surgeries reduced hepatic steatosis in type 2 diabetes at one year
Patients who were randomized to either sleeve gastrectomy or Roux-en-Y gastric bypass showed similar improvements in hepatic steatosis and fibrosis, a randomized trial in Norway found.
https://diabetes.acponline.org/archives/2021/12/10/6.htm
10 Dec 2021
Canagliflozin can lead to statin toxicity, case report finds
A case report describes a patient who had taken rosuvastatin for five years and had new muscle pain and difficulty ambulating two weeks after initiation of canagliflozin.
https://diabetes.acponline.org/archives/2020/08/14/6.htm
14 Aug 2020
SGLT-2 inhibitor-associated ketoacidosis—a history lesson
In a new Annals On Call podcast, host Robert M. Centor, MD, MACP, analyzes ketoacidosis associated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors with guest Bruce R. Leslie, MD, FACP.
https://diabetes.acponline.org/archives/2020/04/10/7.htm
10 Apr 2020
ACP Journal Club: SGLT-2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes
The results of this meta-analysis of sodium-glucose cotransporter-2 (SGLT-2) inhibitors highlight the opportunity for internists, nephrologists, endocrinologists, and cardiologists to collaborate to expand use of the drug class, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2023/03/10/7.htm
10 Mar 2023